BioAge Labs Inc.
XNAS:BIOA 4:00:00 PM EDT
| Market Cap (Intraday) | 854.24M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $21.06 |
| 50-Day MA | $18.47 |
| 200-Day MA | $9.02 |
BioAge Labs Inc. Stock, XNAS:BIOA
1445A South 50th Street, Richmond, California 94804
United States of America
Phone: +1.510.806.1445
Number of Employees:
Description
BioAge Labs, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapeutic products for metabolic diseases, such as obesity, by targeting the biology of human beings. It offers Azelaprag, a potential oral therapeutic for obesity, followed by several earlier-stage metabolic programs. The company was founded by Kristen Fortney and Eric Morgen on April 1, 2015 and is headquartered in Richmond, CA.